8th March 2021 10:29 am 8th March 2021 12:01 pm
Engineers are developing a retinal implant that works with camera-equipped smart glasses and a microcomputer to one day give blind people a form of artificial vision.
This is the claim of a team led by Diego Ghezzi, who have been developing the system since 2015.
“Our system is designed to give blind people a form of artificial vision by using electrodes to stimulate their retinal cells,” said Ghezzi, who holds the Medtronic Chair in Neuroengineering (LNE) at EPFL’s School of Engineering in Lausanne, Switzerland.
The camera embedded in the smart glasses captures images in the wearer’s field of vision, and sends the data to a microcomputer placed in one of the eyeglasses’ end-pieces. The microcomputer turns the data into light signals which are transmitted to electrodes in the retinal implant. The electrodes then stimulate the retina in such a way that the wearer sees a simplified, black-and-white version of the
Retinal Prostheses Poised to Provide Artificial Vision to the Blind genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Being able to make blind people see again sounds like the stuff of miracles or even science fiction. And it has always been one of the biggest challenges for scientists. Diego Ghezzi, who holds the Medtronic Chair in Neuroengineering (LNE) at EPFL's School of Engineering, has made this issue a research focus.
Retinal implants can give artificial vision to the blind eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Studies evaluate ovarian cancer surgery outcomes and clinical standards
These studies were supported financially by the Medtronic Chair in Surgical Training and Research and a research grant from the Carlos III-FEDER Institute of Health.
The introduction of optimal surgery in the treatment of advanced ovarian cancer in order to achieve complete cytoreduction has had the main objective of increasing survival and providing a definitive diagnosis for patients that will allow some cases to be cured.
However, it is highly aggressive and often presents serious post-operative complications that can cause an increase in patient mortality and the delay or impossibility of adjuvant oncological treatment.